ARCHIVES

DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy

This article is from The Cancer Letter archive.

Vol. 14 No. 22 | May 27, 1988

Download PDF Visit The Full Archive

Related Articles

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

PDX Shows 27% Response In T-Cell Lymphoma In Study

December 26, 2008

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990